Apelin receptor agonist - a novel oral therapeutic agent to treat Alzheimer’s disease

View Statistics Email Alert RSS Feed

Grant Data
Project Title
Apelin receptor agonist - a novel oral therapeutic agent to treat Alzheimer’s disease
Principal Investigator
Dr Ng, Chun Laam   (Principal Investigator (PI))
Co-Investigator(s)
Professor Leung Kenneth Mei Yee   (Co-Investigator)
Dr Chan Koon Ho   (Co-Investigator)
Duration
34
Start Date
2019-07-01
Completion Date
2023-11-13
Amount
1245348
Conference Title
Apelin receptor agonist - a novel oral therapeutic agent to treat Alzheimer’s disease
Keywords
agonist, Alzheimer’s, Apelin, disease, receptor, therapeutic
Discipline
Others - Medicine, Dentistry and Health
HKU Project Code
06172306
Grant Type
Health and Medical Research Fund - Full Grant
Funding Year
2018
Status
Completed
Objectives
We aim to study the potential use of CMF-019 as an oral therapeutic treatment for Alzheimer's Disease (AD) by increasing neuronal glucose uptake and insulin sensitization